Source abstract
Abstract
Abstract Neutrophils are crucial for fighting invading pathogens and for the clearance of sterile wounds. However, in cases of overwhelming pathogens or excessive inflammatory responses, fine‐tuning of neutrophil functions can help to either enhance bacterial killing or prevent unwanted tissue damage. Thus, the present study is aimed at developing a nanoparticle‐based toolbox to direct neutrophils toward either a proinflammatory or reparative phenotype tailored to the specific inflammatory environment. For this, neutrophil‐specific fluorine nanoparticles additionally equipped with either activating or inhibiting peptides for a background‐free 19 F MRI‐based theranostic approach are engineered. It is demonstrated that with this i) distinct effector functions can be specifically modulated in both murine and human neutrophils, ii) the disease‐specific degree of neutrophil infiltration can be non‐invasively monitored in vivo, and in turn iii) neutrophil effector functions can either be attenuated during a pharmacological challenge or amplified to ameliorate tissue damage during bacteria‐driven acute colitis. Thus, this nanotheranostic approach is suitable to visualize and concomitantly direct neutrophil functionality depending on the specific requirements to improve disease course and outcome, thus paving the way for a personalized neutrophil immunotherapy.
Source: crossref · Quality: baseline
Affiliations
Experimental Cardiovascular Imaging Molecular Cardiology Heinrich Heine University 40225 Düsseldorf Germany
Institute for Translational Pharmacology Heinrich Heine University 40225 Düsseldorf Germany
Institute of Physical Chemistry 1 Heinrich Heine University 40225 Düsseldorf Germany
Department of Anesthesiology University Hospital Düsseldorf 40225 Düsseldorf Germany
Institute of Chemistry Physical Chemistry of Functional Polymers Martin Luther University Halle‐Wittenberg 06120 Halle (Saale) Germany
Cardiovascular Research Institute Düsseldorf (CARID) Heinrich Heine University Düsseldorf Germany
Funding
Deutsche Forschungsgemeinschaft